November 13, 2020
A small drugmaker is accusing the U.S. Food and Drug Administration in Maryland federal court of disregarding false information in a Lannett Co. application for a cocaine-based numbing agent, the latest chapter in the company's efforts to protect its cocaine anesthetic that has been on the market for years.